[ad_1]
NEW YORK (Reuters Health) – The daily use of aspirin can increase the resilience of cancer patients by 78 percent, according to researchers at the University of California at San Francisco.
The group of scientists hoped to establish a natural association between the use of nonsteroidal anti-inflammatory drugs and the increased resilience of cancer patients with the PIK3CA gene, according to a study published in the Journal of Experimental Medicine.
During the study, scientists used data from 266 cancer patients who survived five years after head and neck cancer – malignant tumors can appear in more than 30 areas of the world. these parts of the body, especially the mouth and the throat. In 75 people, tumors were found on the gene above.
The patients, carriers of the mutated gene, regularly took aspirin for six months, increasing their chances of survival for five years, from 25 to 78%.
Source: Novosti
[ad_2]
Source link
